Phosphoproteome of Resting Human Platelets

René P. Zahedi, Urs Lewandrowski, Julia Wiesner, Stefanie Wortelkamp, Jan Moebius, Claudia Schütz, Ulrich Walter, Stepan Gambaryan§ and Albert Sickmann*
Rudolf Virchow Center/DFG Research Center for Experimental Biomedicine, University of Würzburg, Protein Mass Spectrometry and Functional Proteomics Group, Würzburg, D-97078 , Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, D-97080 , and Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, 194223
J. Proteome Res., 2008, 7 (2), pp 526–534
DOI: 10.1021/pr0704130
Publication Date (Web): December 19, 2007
Copyright © 2008 American Chemical Society

Rudolf Virchow Center/DFG Research Center for Experimental Biomedicine, University of Würzburg.

,

Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg.

,
§

Russian Academy of Sciences.

,
* To whom correspondence should be addressed: Rudolf Virchow Center/DFG Research Center for Experimental Biomedicine, University of Würzburg, Protein Mass Spectrometry and Functional Proteomics Group, Room 411, Versbacher Strasse 9, 97078 Würzburg, Germany. Telephone: +49-(0)-931-201-48730 . Fax: +49-(0)-931-201-48123. E-mail: albert.sickmann@virchow.uni-wuerzburg.de.

Abstract

Abstract Image

Beside their main physiological function in hemostasis, platelets are also highly involved in pathological processes, such as atherothrombosis and inflammation. During hemostasis, binding of adhesive substrates to tyrosine-kinase-linked adhesion receptors and/or soluble agonists to G-protein coupled receptors leads to a cascade of intracellular signaling processes based on substrate (de)phosphorylation. The same mechanisms are involved in platelet activation at sites of atherosclerotic plaque rupture, contributing to vessel occlusion and consequently to pathologic states, such as myocardial infarction, stroke, or peripheral artery disease. To gain a deeper insight into platelet function, we analyzed the phosphoproteome of resting platelets and identified 564 phosphorylation sites from more than 270 proteins, of which many have not been described in platelets before. Among those were several unknown potential protein kinase A (PKA) and protein kinase G (PKG) substrates. Because platelet inhibition is tightly regulated especially by PKA and PKG activity, these proteins may represent important new targets for cardiovascular research. Thus, our finding that GPIbα is phosphorylated at Ser603 in resting platelets may represent a novel mechanism for the regulation of one of the most important platelet receptor (GPIb-IX-V) mediated signaling pathways by PKA/PKG.

Tools

History

  • Published In Issue February 01, 2008
  • Article ASAPDecember 19, 2007
  • Received: July 4, 2007
    Accepted: November 7, 2007

Recommend & Share

Related Content

Other ACS content by these authors: